Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - MSN
3 days ago • Google News
Zai Lab Ltd (ZLAB)
US$ 32-5.33%
Price Chart
Key Statistics
Market Cap
$ 3.18B
P/E Ratio
0.00
Revenue (TTM)
$ 398.99M
Volume
1.67M
52W High
$ 39.77
52W Low
$ 16.01
Dividend Yield
0.00%
Beta
1.04
Technicals
50-Day MA
32.9302
200-Day MA
27.1494
52 Week High
39.77
52 Week Low
16.01
About ZLAB
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and i.
Employees
1869
Headquarters
Shanghai, China
CEO
Dr. Ying Du Ph.D.
Latest News
Zai Lab Limited (NASDAQ:ZLAB) Q1 2025 Earnings Call Transcript - Insider Monkey
2 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg